兒童醫療保健市場規模、佔有率和成長分析(按疾病類型、治療領域、治療方法和地區分類)-2026-2033年產業預測
市場調查報告書
商品編碼
1899487

兒童醫療保健市場規模、佔有率和成長分析(按疾病類型、治療領域、治療方法和地區分類)-2026-2033年產業預測

Pediatric Healthcare Market Size, Share, and Growth Analysis, By Diseases Type (Short Term Diseases, Chronic Diseases), By Therapeutics (Cardiology, Allergy And Immunology), By Treatment, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到 2024 年,全球兒童醫療保健市場規模將達到 136.6 億美元,到 2025 年將達到 142.6 億美元,到 2033 年將達到 201.2 億美元,預測期(2026-2033 年)的複合年成長率為 4.4%。

全球兒童醫療保健市場是一個充滿活力且快速發展的行業,致力於透過各種醫療服務、治療方法和產品來改善兒童的健康和福祉。人口年輕化和人們對兒童醫療保健挑戰的認知不斷提高是推動市場成長的主要因素。關鍵成長要素包括技術創新、醫療費用支出增加以及對預防性護理日益重視。該市場涵蓋滿足兒童特定醫療需求的各個細分領域,包括診斷、治療、疫苗、醫療設備和支援服務。該市場的特點是跨國公司、區域性企業和創新新興企業之間競爭激烈,它們都試圖透過研發、策略聯盟、併購和產品發布來獲取市場佔有率,最終塑造專業兒童醫療保健的未來發展方向。

全球兒童醫療保健市場促進因素

全球兒童醫療保健市場的主要驅動力之一是人們對預防性醫療保健的日益重視。人們越來越認知到早期發現、及時介入和預防措施在保護兒童健康方面的重要作用。這種意識源於減少兒童疾病長期影響和改善兒童整體健康狀況的需要。定期體檢、疫苗接種和健康檢查等預防性醫療保健措施正日益受到重視,這些措施能夠及早發現並解決潛在的健康問題,從而確保兒童未來的健康成長。

全球兒童醫療保健市場面臨的限制因素

全球兒童醫療保健市場面臨的主要挑戰之一是為兒童提供專業服務和治療的高昂成本。提供專業護理通常需要先進的技術、特製藥物以及具備小兒科知識的醫護人員,所有這些都會增加成本。這種經濟負擔對家庭來說尤其沉重,尤其是在缺乏經濟實惠的醫療保健選擇和充足保險覆蓋的地區。因此,高昂的費用可能會使一些兒童無法獲得高品質的醫療保健。這可能導致醫療保健結果的差異,並阻礙整個市場的成長。解決這些與成本相關的問題對於促進公平地獲得兒童醫療保健至關重要。

全球兒童醫療保健市場趨勢

全球兒童醫療保健市場的一大趨勢是日益重視針對兒童的個人化和精準醫療。這種方法認知到兒童群體獨特的生理、遺傳和發育特徵,並優先考慮根據每位兒童的個別特徵和需求量身定做醫療干預措施。基因組學、分子診斷和生物標記識別等技術進步正在推動這項變革,使醫療服務提供者能夠實施更具針對性和個人化的治療策略。透過關注這些獨特的生物學和遺傳變異,這一趨勢旨在提高治療效果、減少副作用,並最終改善兒童醫療機構的整體患者照護。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數(2025)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 監管環境
  • 案例研究
  • 技術進步

全球兒童醫療保健市場規模(按疾病類型和複合年成長率分類)(2026-2033 年)

  • 短期疾病
  • 慢性病
  • 其他

全球兒童醫療保健市場規模(依治療領域分類)及複合年成長率(2026-2033 年)

  • 心臟病學
  • 過敏與免疫學
  • 胃腸病學
  • 感染疾病
  • 其他

全球兒童醫療保健市場規模(按治療方法和複合年成長率分類)(2026-2033 年)

  • 疫苗
  • 藥品
  • 外科手術
  • 其他

全球兒童醫療保健市場規模(按地區分類)及複合年成長率(2026-2033 年)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析(2025 年)
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

主要企業簡介

  • Eli Lilly and Company(United States)
  • Maven(United States)
  • InStride Health(United States)
  • Shorla Oncology(Ireland)
  • Amgen(United States)
  • Backpack Healthcare(United States)
  • Moderna Therapeutics(United States)
  • Summer Health(United States)
  • Novartis AG(Switzerland)
  • AstraZeneca(United Kingdom)
  • Bristol-Myers Squibb Company(United States)
  • AMMT(United Arab Emirates)
  • King Faisal Specialist Hospital and Research Centre(Saudi Arabia)
  • VPS Healthcare(United Arab Emirates)
  • Creche Innovations(United States)
  • Bodypoint(United States)
  • Dechoker(United States)
  • eBroselow(United States)
  • Graco Children Products(United States)

結論與建議

簡介目錄
Product Code: SQMIG35I2175

Global Pediatric Healthcare Market size was valued at USD 13.66 Billion in 2024 and is poised to grow from USD 14.26 Billion in 2025 to USD 20.12 Billion by 2033, growing at a CAGR of 4.4% during the forecast period (2026-2033).

The global pediatric healthcare market represents a vibrant and rapidly evolving sector that focuses on enhancing the health and well-being of children through a diverse array of medical services, treatments, and products. Growth is being propelled by a rising youth population and greater awareness of pediatric health challenges. Key drivers include technological innovation, heightened healthcare spending, and an emphasis on preventive care. This market encompasses various segments such as diagnostics, therapeutics, vaccines, medical devices, and support services, designed to address the unique healthcare needs of children. It is characterized by intense competition among multinational corporations, regional entities, and innovative startups aiming for market share through R&D, strategic alliances, mergers, and product launches, ultimately shaping a future focused on specialized pediatric care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pediatric Healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pediatric Healthcare Market Segments Analysis

Global Pediatric Healthcare Market is segmented by diseases type, therapeutics, treatment and region. Based on diseases type, the market is segmented into short term diseases, chronic diseases and others. Based on therapeutics, the market is segmented into cardiology, allergy & immunology, gastroenterology, infectious disease and others. Based on treatment, the market is segmented into vaccines, medication/ drugs, surgery and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pediatric Healthcare Market

A significant driving force behind the global pediatric healthcare market is the heightened awareness and focus on preventive care. There is an increasing understanding of the critical role that early detection, prompt interventions, and proactive measures play in safeguarding children's health. This awareness is motivated by the need to reduce the long-term effects of pediatric illnesses and enhance the overall well-being of young patients. Initiatives centered on preventive care, such as regular check-ups, vaccinations, and health screenings, are gaining priority to identify and tackle potential health concerns early on, ensuring healthier outcomes for children in the future.

Restraints in the Global Pediatric Healthcare Market

A significant challenge facing the global pediatric healthcare market is the elevated expense associated with providing services and treatments specifically for children. Delivering specialized care often requires advanced technologies, unique medications, and healthcare professionals with expertise in pediatrics, all of which contribute to increased costs. This financial burden can be particularly heavy for families, especially in areas where affordable healthcare options or adequate insurance coverage are lacking. Consequently, the high expenses may restrict access to quality care for some children, leading to disparities in healthcare outcomes and potentially hindering overall market growth. Addressing these cost-related issues is crucial for promoting equitable access to pediatric healthcare.

Market Trends of the Global Pediatric Healthcare Market

A prominent trend in the global pediatric healthcare market is the increasing emphasis on personalized and precision medicine tailored specifically for children. This approach prioritizes customizing medical interventions based on the individual characteristics and needs of young patients, acknowledging the distinctive physiological, genetic, and developmental traits inherent in pediatric populations. Advancements in technologies like genomics, molecular diagnostics, and biomarker identification are driving this shift, allowing healthcare providers to implement more targeted and individualized treatment strategies. By focusing on these unique biological and genetic variations, the trend aims to enhance treatment efficacy, reduce adverse effects, and ultimately improve overall patient care in pediatric healthcare settings.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies
  • Technological Advancement

Global Pediatric Healthcare Market Size by Diseases Type & CAGR (2026-2033)

  • Market Overview
  • Short Term Diseases
  • Chronic Diseases
  • Others

Global Pediatric Healthcare Market Size by Therapeutics & CAGR (2026-2033)

  • Market Overview
  • Cardiology
  • Allergy And Immunology
  • Gastroenterology
  • Infectious Disease
  • Others

Global Pediatric Healthcare Market Size by Treatment & CAGR (2026-2033)

  • Market Overview
  • Vaccines
  • Medication/ Drugs
  • Surgery
  • Others

Global Pediatric Healthcare Market Size & CAGR (2026-2033)

  • North America (Diseases Type, Therapeutics, Treatment)
    • US
    • Canada
  • Europe (Diseases Type, Therapeutics, Treatment)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Diseases Type, Therapeutics, Treatment)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Diseases Type, Therapeutics, Treatment)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Diseases Type, Therapeutics, Treatment)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Eli Lilly and Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Maven (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • InStride Health (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shorla Oncology (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amgen (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Backpack Healthcare (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Moderna Therapeutics (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Summer Health (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AstraZeneca (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bristol-Myers Squibb Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AMMT (United Arab Emirates)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • King Faisal Specialist Hospital and Research Centre (Saudi Arabia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • VPS Healthcare (United Arab Emirates)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Creche Innovations (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bodypoint (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dechoker (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • eBroselow (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Graco Children Products (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations